Parkinson's Disease Trial, Recruiting NCT05516719 Sponsor: University of Exeter Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05516719
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to understand what the study involves and be willing to sign a consent form agreeing to take part.
  • You must be willing and able to attend all scheduled visits and complete all required study procedures and tests.
  • You must be able to travel to the research site for study procedures.
  • You must be 25 years old or older.
  • If you are a woman, you must either be unable to become pregnant (due to surgery or natural menopause lasting at least 12 months), or if you could become pregnant, you must not currently be pregnant (confirmed by a urine test) and must not be breastfeeding.
  • All participants must use a highly effective form of birth control throughout the study (such as hormonal contraception, an IUD, tubal ligation, a vasectomised partner, or abstinence).
  • If you are a sexually active man, you must agree to use condoms and ensure effective contraception is used during the study and for 3 months after your last scan, to prevent pregnancy in a partner.
  • You must have adequate vision and hearing to complete the psychological tests, as judged by the study doctor.
  • You must not be taking any medications known to interact with a specific brain receptor being studied (confirm with trial site for the full list of medications).
  • If you take certain medications that could affect brain imaging results, you must be willing and able to safely stop taking them for a required period before your scan (confirm with trial site).

Who may not be able to join:

  • You may not be eligible if the study doctor believes you are unable to make informed decisions for yourself.
  • You may not be eligible if you have been diagnosed with dementia.
  • You may not be eligible if you currently have or recently had a problem with drug or alcohol misuse.
  • You may not be eligible if you are currently taking blood-thinning medications (such as warfarin or heparin), which could make certain procedures unsafe.
  • You may not be eligible if you have a condition that makes it unsafe to have a lumbar puncture (spinal tap), such as serious spinal disease or a blood clotting problem.
  • You may not be eligible if a circulation test in both hands (called the Allen test) gives a negative result (confirm with trial site).
  • You may not be eligible if you have taken certain medications that could affect brain imaging within the past 5 months (confirm with trial site for the full list).
  • You may not be eligible if you are currently taking any medications known to affect the specific brain receptor being studied in this trial (confirm with trial site for the full list).
  • You may not be eligible if you have taken part in another clinical trial using an experimental drug or device within the last 60 days.
  • You may not be eligible if you have had cancer in the last 5 years, with the exception of a non-spreading type of skin cancer (basal cell carcinoma).
  • You may not be eligible if you cannot have an MRI scan, for example because you have a pacemaker, metal implants, or metal fragments in your body or eyes.
  • You may not be eligible if you are claustrophobic or have back pain that would make lying still in a scanner for extended periods too difficult.
  • You may not be eligible if a previous MRI scan showed a significant brain or neurological condition, in the opinion of the study doctor.
  • You may not be eligible if you have any significant ongoing medical condition that the study doctor believes could be unstable, could get worse during the study, or could put you at risk.
  • You may not be eligible if you have a history of suicidal behaviour or are currently having thoughts of suicide.
  • You may not be eligible if you are pregnant, breastfeeding, or plan to become pregnant within the next 18 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Exeter
Registry
ClinicalTrials.gov
Start date
1 November 2021
Est. completion
30 June 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

PET scan with BU99008 to highlight I2BS and and Astroglia cells.; Single Photon Emission Computed Tomography (SPECT) to measure brain molecular pathology; Magnetic Resonance Imaging (MRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov